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ABSTRACT
Hypoperfusion or decrease in blood  ow is may cause organ failure. When the body experiences hypoperfusion, 
body perfusion is prioritized to brain and heart, which may cause the hypoperfusion of splanchnic organ. 
Splanchnic hypoperfusion will cause ischemia of the mucosa, disturbance in the barrier, and increased splanchnic 
permeability, which in further level mayl cause bacterial and endotoxin translocation to systemic circulation.
Enteral feeding in hypoperfusion is bene cial to prevent splanchnic hypoperfusion. However, method of enteral 
feeding needs to be considered, so that it does not cause harmful adverse effects. Early enteral feeding by slow 
continuous drip method can prevent splanchnic failure in critically ill patients with high risk of hypoperfusion. 
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ABSTRAK
Hipoperfusi atau penurunan aliran darah sangat berisiko menyebabkan gagal organ. Pada saat tubuh 
mengalami hipoperfusi, prioritas perfusi tubuh adalah organ tertentu yaitu otak dan jantung, yang berakibat 
saluran cerna mengalami hipoperfusi. Hipoperfusi saluran cerna akan menyebabkan iskemia mukosa, gangguan 
sawar dan peningkatan permeabilitas saluran cerna, yang pada tahap selanjutnya berakibat translokasi bakteri 
dan endotoksin ke sirkulasi sistemik.
 Pemberian nutrisi enteral pada hipoperfusi bermanfaat mencegah hipoperfusi saluran cerna. Meskipun 
demikian cara pemberian nutrisi enteral tetap perlu diperhatikan agar tidak menimbulkan efek samping yang 
merugikan. Pemberian nutrisi enteral dini dengan cara kontinyu tetesan lambat dapat mencegah kegagalan 
saluran cerna pada pasien sakit kritis dengan resiko tinggi hipoperfusi. 
Kata kunci: hipoperfusi saluran cerna, nutrisi enteral, metode tetesan lambat
INTRODUCTION
Splanchnic hypoperfusion is commonly found in 
critically ill patients, which are: trauma, sepsis, burn 
wound. Hypoperfusion may cause ischemia of the 
mucosa, disturbance of gut barrier, and splanchnic 
permeability increased, which may further induce 
bacterial translocation. Bacterial translocation may 
cause sepsis. Hypoperfusion alone or which is followed 
by sepsis may cause multiple organ failure. Splanchnic 
hypoperfusion is one of the factors which is related to 
morbidity and mortality in critically ill patients.1 
Enteral feeding is preferable in nutritional support 
of critically ill patients because it gives more bene t 
physiologically compared to parenteral.2 The aim of 
this review article is to discuss one of the enteral feeding 
roles, which is to prevent splanchnic hypoperfusion and 
fatal consequences which may happen to critically ill 
patients.
SPLANCHNIC HYPOPERFUSION
Splanchnic perfusion or blood  ow is supplied by 
three branches of the aorta, which are: celiac artery, 
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superior mesenteric artery, and inferior mesenteric 
artery.3,4 Celiac artery supplies blood to the stomach, 
liver, and spleen. Superior mesenteric artery supplies 
blood to the intestine, proximal colon, and pancreas. 
Inferior mesenteric artery supplies blood to distal 
colon. The entire splanchnic blood perfusion comes 
from 20-25% of cardiac output. In the resting state, 
70% blood which  ow to the splanchnic,  ow to the 
mucosal lining, 15-25% to the muscular and serousal 
layer, also 5% to submucosa. Blood  ow to the mucosa 
is divided into 2 parts, which are 60% supplies the 
epithelial cells on the vili and 40% supplies the crypts 
and goblet cells. This splanchnic perfusion need to be 
maintained to ful l the need of oxygen and nutrition to 
the tissue, also to excrete metabolic waste products.3,5
Decreased perfusion or hypoperfusion can be caused 
by heart failure, haemorrhage, dehydration, infection, 
allergic reaction, and vasoactive drugs administration. 
In the cell, as a consequence of hypoperfusion, cell 
may experience oxygen deprivation (hypoxia), then 
may further experience injury (ischemia), and  nally 
may experience death (necrosis). In splanchnic organs, 
hypoperfusion can be caused by shock condition as a 
body mechanism of compensation to maintain blood 
 ow to the brain.3 
Splanchnic hypoperfusion may cause mucosal 
ischemia.6-9 Mucosal ischemia marks the presence of 
disturbance in splanchnic barrier. Splanchnic barrier 
is a defence mechanism which functions to maintain 
splanchnic permeability. Disturbance in splanchnic 
barrier causes splanchnic permeability increase and 
enables bacterial and endotoxin translocation to 
systemic tissue.6-9 Bacterial and endotoxin translocation 
to the systemic circulation causes the release of pro-
in ammatory mediators which cause the occurrence of 
sepsis and if continues, may lead to organ failure, or even 
multiple organ failure. The occurrence of multiple organ 
failure, which is related to splanchnic hypoperfusion 
in critically ill patients, showed important role of the 
splanchnic. Therefore, this role has to be maintained, 
one of the ways is through enteral feeding.2,7-8,10
ENTERAL FEEDING
De nition, Form, and Method of Administration
Enteral feeding, according to the de nition by the 
European legal regulation of the commission directive 
is all form of nutritional support which use food for 
particular therapy purpose.11 Enteral feeding, based on 
the way of presentation, can be in the form of clear or 
thick liquid, depending on its content. Indications of 
enteral feeding for patients are: (1) good splanchnic 
function; (2) in ongoing or predicted to experience 
malnutrition; (3) cannot reach optimal nutritional 
status by using oral intake alone.11 Based on method 
of administration, enteral feeding can be given as 
oral nutritional supplement (ONS) or administered 
through pipe. Based on the nutritional content, enteral 
feeding may contain complete nutrition as main 
nutritional source or incomplete nutritional source, 
which is not as main nutritional source. Based on the 
composition, standard enteral feeding, which contains 
appropriate composition to the average need of a 
healthy population, or special enteral feeding, which 
is tailored according to particular need of a disease.12
Enteral feeding based on its form is divided into 
polymer and monomer enteral feeding. Polymer 
enteral feeding contains macronutrients in the form 
of whole protein, triglycerides, and carbohydrate 
polymer. Monomer enteral feeding contains protein 
in the form of peptides or amino acid, long chain or 
combination of long and medium chain fatty acid, also 
partially hydrolyzed starch maltodextrin or glucose 
oligosaccharides.12 Other characteristic of enteral 
feeding which needs to be considered is osmolarity, 
which generally ranges between 300 and 500 mOsm, 
nearing body  uid osmolarity (300 mOsm).13 
There are three choices in administration method 
of enteral feeding through pipes, which are bolus, 
intermittent drip, and continuous drip.13 Bolus method 
is administering enteral feeding in the amount 
between 240-480 mL with 10-20 minutes duration 
of administration and bolus frequency according 
to patient’s need, usually every 4-6 hours per day. 
Intermittent drip method is administering enteral 
feeding based on principle of gravitation, volume 
to be achieved is approximately 240-720 mL in 20-
60 minutes. Similar to bolus method, frequency of 
administration in intermittent method is also every 4 to 
6 hours/day. Last method is continuous drip, which is 
administering enteral feeding dropwise continuously. 
The administration needs pump to administer enteral 
feeding with constant volume per unit time.14 
Installation of enteral feeding access can be 
performed manually, with the help of endoscopy, or 
with surgical technique. The choice is based on the 
presence or absence of splanchnic obstruction and 
administration duration. Locating the end of enteral 
feeding pipe in the stomach or jejunum, is based on 
the presence of aspiration risk.13
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ADMINISTRATION OF ENTERAL FEEDING IN 
SPLANCHNIC HYPOPERFUSION
Presence of nutrition in the splanchnic will increase 
blood  ow, which is known as postprandial hyperaemia 
mechanism.3 Someya et al, stated that increased blood 
 ow after meal which happened in the splanchnic was 
approximately 58-250%.15 This increase of blood  ow 
would persist for 2-3 hours, reaching the peak within 
5-60 minutes after administration. Different enteral 
feeding would give different effect in the increase 
and duration of postprandial hyperaemia to occur.15 
Studies to know the effect of each glucose, amino acid, 
and fat to increase of splanchnic blood  ow has been 
performed by Brundin et al and Gielkens et al. The 
highest increased velocity of splanchnic blood  ow 
happens in glucose administration followed by amino 
acid and fat.16-18
Mechanism of increased blood  ow in splanchnic 
due to enteral feeding is the basic idea that enteral 
feeding can prevent splanchnic hypoperfusion. Study 
conducted by Had eld et al, concluded that splanchnic 
dysfunction in critically ill patient could be corrected 
with enteral feeding.19 Kompan et al, in their study 
showed that early enteral feeding (< 6 hours intensive 
care unit (ICU) hospitalization) in multiple trauma 
patients could maintain splanchnic permeability and 
prevent more severe multiple organ dysfunction.20 
Study performed by Fukatsu et al, stated that early 
enteral feeding might prevent increased of splanchnic 
permeability and further decrease mortality rate.21 These 
three studies showed that enteral feeding is proved to 
improve absorption ability and decrease splanchnic 
permeability in splanchnic hypoperfusion.19-21 Presence 
of side effects of enteral feeding in critically ill patients 
has been reported in a study by Marvin et al, in which 
it was obtained that splanchnic necrotic incidence was 
approximately 0.3-8.5%.22 Therefore, enteral feeding 
in patients with high risk of splanchnic ischemia need 
to consider many matters (Table 1).23
in critically ill patients. The success of early enteral 
feeding is in uenced by dose.24 Administration of 
enteral feeding with continuous slow drip method 
(trickle or trophic feeds), which is approximately 10-
20 ml/hour can prevent splanchnic mucosal atrophy.25 
CONCLUSION
One way to prevent splanchnic hypoperfusion 
and its fatal consequences is by administering enteral 
feeding. Enteral feeding in splanchnic hypoperfusion 
may improve decreased absorption ability, prevent 
increase splanchnic permeability, and prevent more 
severe multiple organ failure. Recommended method 
of enteral feeding to prevent splanchnic hypoperfusion 
and its consequences is by continuous slow drip 
method.
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